Chemed updates 2025 forecast as Q1 revenue shows continued growth

Chemed Corporation (NYSE:CHE) is one of the 11 Best Long Term Low Risk Stocks to Invest in.

Analysts are dropping the price target on the stock after the company lowered its earnings guidance for 2025.

Ohio-based company, Chemed Corporation (NYSE:CHE) operates two main subsidiaries, VITAS Healthcare and Roto-Rooter. VITAS provides hospice and palliative care, while Roto-Rooter offers plumbing, drain cleaning, and water restoration services. With these distinct healthcare and essential home services platforms, the company serves both residential and commercial markets across the U.S.

On June 27, 2025, Chemed Corporation (NYSE:CHE) announced that it has lowered its full-year earnings guidance for 2025, as it expects lower earnings for the second quarter. The revenue for the first quarter stood at $646.9 million, a 9.8% year-on-year growth.

Following the announcement, Bank of America lowered its price target on the stock from $708 to $650 but maintains the Buy rating on the shares. RBC capital reflected the sentiment and reduced the price target accordingly, from $674 to $640, while keeping an Outperform rating.

Trading at $453.65 as of July 23, 2025, Chemed Corporation (NYSE:CHE)’s beta of 0.47 signals low volatility, while its EPS of 5.86% for the next 5 years indicates moderate but long term growth for interested investors.

While we acknowledge the potential of CHE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 10 Metal Stocks with Insider Buying in 2025 and 10 Energy Stocks with Insider Buying in 2025

Disclosure. None.